EGFR Exon 20 Insertion (A763_Y764insFQEA) Mutant NSCLC Is Not Identified by Roche Cobas Version 2 Tissue Testing but Has Durable Intracranial and Extracranial Response to Osimertinib

J Thorac Oncol. 2020 Oct;15(10):e162-e165. doi: 10.1016/j.jtho.2020.05.006.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acrylamides
  • Aniline Compounds
  • ErbB Receptors / genetics
  • Exons / genetics
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Mutation

Substances

  • Acrylamides
  • Aniline Compounds
  • osimertinib
  • EGFR protein, human
  • ErbB Receptors